Related Experiment Video
Updated: Apr 8, 2026

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
Published on: January 21, 2018
An Update in Laser and Pharmaceutical Treatment for Polypoidal Choroidal Vasculopathy
Timothy Y Y Lai1, Wai-Man Chan
1From the *Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong; †2010 Retina and Macula Centre, Kowloon; and ‡Department of Ophthalmology, Hong Kong Sanatorium and Hospital, Hong Kong.
Abstract:
Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, recurrent, serosanguineous pigment epithelium detachment and neurosensory retinal detachment due to abnormal choroidal polypoidal lesions. Polypoidal choroidal vasculopathy is particularly prevalent in Asians and occurs in up to 30% of patients presenting with neovascular age-related macular degeneration. In recent years, various treatment modalities have been described in the literature for the treatment of PCV. This review article aims to provide an overview and to summarize the current nonsurgical treatment for PCV.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Peripheral Artery Disease III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Ophthalmic Drug Delivery Systems

